Tue, Sep 29 · 9:00

Entitled ‘Pharma in the Age of Value and Affordability’, this event has been designed for board and C-level executives from across the life sciences sector to discuss strategies to prepare and remain relevant and in an increasingly value-driven and personalized healthcare market.

The Summit will feature an outstanding line-up of speakers sharing their insights, ideas and expertise on topics to include the increasingly complex and uncertain political and pricing environment, the industrialization of cell and gene therapies, and the coming of age of real-world-evidence (RWE).

YouTube: https://go.evvnt.com/584052-3?pid=5731
Twitter: https://go.evvnt.com/584052-4?pid=5731

Price: Standard Ticket: USD 1350.00

Speakers: Jessica Mega, Chief Medical and Scientific Officer, Verily Life Sciences, Daphne Koller, CEO and Founder, Insitro, Alexander Hardy, CEO, Genentech, Ofer Leidner, Co-Founder and President, Happify Health, Husseini Manji, Global Therapeutic Head for Neuroscience, Janssen Research and Development, Sandy Macrae, Founder and Chief Executive Officer, Sangama Therapeutics, Peter Bach, Director, Center for Health Policy and Outcomes, Memorial Sloan Kettering Cancer Center, Susan Shiff, Senor Vice President, Observational and Real-World Evidence, Merck, David Altshuler, Executive Vice President, Global Research and Chief Scientific Officer, Vertex, Bernard Hamelin, Global Head of Medical Evidence Generation, Sanofi, Terry Wilcox, Co-Founder and Executive Director, Patients Rising

Venue details: Convene, 730 Third Avenue, New York, New York, 10017, United States